Pub. Date : 2018 Feb
PMID : 28971495
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Herein, we described the first report of a patient with relapsed chronic lymphocytic leukaemia harbouring TP53 abnormalities who developed, histologically proven, systemic light chain amyloidosis who was treated with the PI3K inhibitor, idelalisib, and rituximab. | idelalisib | tumor protein p53 | Homo sapiens |